Fundraising FoxAI & Machine Learning Startups
31,739 companies tagged AI & Machine Learning, with their investors and founders.
Caribou provides an employee referral and recruitment tool for care communities, letting caregivers share job openings with qualified candidates and rewarding both effort and results. It integrates with existing applicant tracking systems (or offers its own) to give employers visibility into the hiring pipeline and improve caregiver retention.
3 investors
Cariina offers an all-in-one platform that integrates and manages school operations and administrative processes, replacing multiple separate tools with a single system. It serves K-12 schools and their educators and department heads, operating in the edtech sector in the United States.
3 investors
Cartesian Kinetics develops "Physical AI" for fulfillment and warehouse operations, combining automation software and rack-native robotics that work within a facility's existing racks, systems and workflows rather than requiring a rebuild. It serves operators looking to modernize industrial and warehouse automation incrementally.
3 investors
Cascade builds an agentic AI layer that sits across enterprise systems of record such as HRIS, ITSM, and benefits administration, deploying AI agents that interpret employee intent, enforce policy, and execute end-to-end workflows like onboarding, equipment requests, and benefits enrollment. It targets large organizations' HR and IT operations in what it calls the Agentic Workflow Automation category.
3 investors
Cascade uses AI to identify and match Request for Proposal (RFP) opportunities to construction and architecture firms by scanning government and private sector portals, then assists in proposal writing and bid management.
3 investors
Cascala develops clinical intelligence tools that combine medicine, engineering, product design, and AI to deliver relevant data at the point of care. The company operates in the healthcare technology space.
3 investors
Cased uses AI to automate cloud infrastructure management, letting developers describe what they want to deploy and where while the tool handles tools like Terraform, Kubernetes, Docker, and AWS. It targets development teams that lack dedicated infrastructure specialists.
3 investors
Cashboard provides a data governance and integration platform that serves as a centralized source of truth for financial data, metrics, and permissions. It enables AI agents and finance teams to access and analyze current financial information through multiple interfaces including an MCP protocol, dashboards, and Excel, while maintaining granular security controls.
3 investors
CashFlo is a financial automation platform that handles accounts payable automation, vendor management, invoice reconciliation, and dealer financing, using OCR, multi-way matching, and machine learning to process invoices and maintain GST compliance. It serves corporate finance teams and integrates with existing ERP systems to help businesses manage working capital and cash flow.
3 investors
Cashmere operates a platform that connects publishers with AI applications, letting publishers license, track, and monetize how their content is accessed by AI platforms at inference time. It serves premium and academic publishers with tools for governed AI discovery, licensing enforcement, payments, and delivery.
3 investors
Cashmere provides identity resolution and enrichment for B2B sales and marketing teams, transforming fragmented customer records into actionable insights through research agents, predictive models, and real-time event tracking. The platform integrates directly into CRMs, data stacks, and sales workflows to deliver verified contact information, wealth data, relationship mapping, and propensity signals.
3 investors
Caspia Technologies builds a GenAI-based security verification platform that integrates with existing chip design flows to detect and help fix security weaknesses in SoC and RTL designs. It serves hardware and semiconductor design teams, extending security assurance into the supply chain through bill-of-materials analysis and counterfeit detection.
3 investors
CastingN (캐스팅엔) builds procurement spend-management software for Korean companies, starting with the country's first indirect-purchasing bidding platform and expanding into medical and healthcare brokerage. It is preparing to launch ZENO, an AI-based indirect-procurement spend-management OS, for enterprise buyers in South Korea.
3 investors
Catalant is a consulting platform that provides capital strategy and investment planning services to enterprises, helping them optimize capital allocation across CapEx, OpEx, and M&A through structured frameworks and AI-enabled intelligence. The company serves large organizations and private equity firms seeking to improve investment decision velocity and financial returns.
3 investors
Catalyst is an AI agent platform that converts a user's trading thesis or idea into a live trading strategy, automatically identifying data feeds and execution venues across news, prediction markets, yield, stocks, commodities, tokens, and private markets. The agents autonomously backtest and execute strategies using deposits in fiat or crypto. The product is in waitlist stage.
3 investors
CaTe develops technology-enabled healthcare solutions that help patients continue necessary medical care in their daily lives after hospital discharge. The company combines medical expertise with IoT, AI, and digital tools to support ongoing treatment adherence and patient monitoring, particularly for cardiac care and post-discharge recovery.
3 investors
Cavalry provides AI agents that analyze customer support tickets, resolve them in a brand-matched voice, and generate weekly reports highlighting urgent issues such as product defects, shipping trends, and billing problems. It is aimed at consumer brands looking to automate and gain insight from their customer support operations.
3 investors
CData provides a centralized data connectivity layer that unifies hundreds of SaaS apps, databases, and on-prem systems behind one relational interface, giving AI agents governed, authenticated, and audited access to live business data via MCP. Its products include a managed MCP platform, change-data-capture replication into warehouses like Snowflake and Databricks, embeddable white-labeled connectivity, a CLI, and a Python SDK for enterprise teams building and scaling production AI.
3 investors
Celero is a data infrastructure platform for legal entities (PJs) in Latin America that uses artificial intelligence to help financial institutions gain comprehensive customer insights and optimize credit expansion for business customers.
3 investors
Celigo provides an AI-powered integration platform (iPaaS) that connects business systems and automates workflows across a company's tech stack. It serves enterprise teams looking to integrate applications, automate processes, and optimize workflows.
3 investors
Cellarity develops medicines using artificial intelligence and single-cell biology to address disease at the cellular level rather than targeting individual disease markers. The company serves patients with challenging diseases through AI-driven drug discovery.
3 investors
CellCo applies computational simulation, generative AI, and medicinal chemistry to design glycan-enabled therapeutics, engineering glycan ligands that direct RNA, small molecules, and antibodies to specific tissues and cell types. It develops platforms for molecular dynamics, synthetic data generation, and foundation models targeting glycan chemistry, immune modulation, and targeted drug delivery.
3 investors
Cellens develops a non-invasive, urine-based cancer diagnostics platform (Octosense) that uses nanoscale atomic-force imaging of single-cell biophysical markers combined with machine learning to detect cancer, with early data focused on bladder cancer detection. It applies mechanobiology and label-free cell analysis to cancer screening.
3 investors
Cellply develops VivaCyte, an automated platform that combines microfluidic consumables, an instrument, and image-analysis software to characterize cell therapies at single-cell resolution. It serves cell therapy discovery and development teams, measuring phenotype and function across thousands of single-cell co-cultures and comparing up to 128 conditions per run.
3 investors